Victoria Wang

Victoria Wang is a physician scientist at the University of California, San Francisco (UCSF), with academic training from Stanford University (BAS/MS), Massachusetts Institute of Technology (PhD), and Harvard Medical School (MD). Her career spans clinical roles at institutions like Brigham and Women’s Hospital and Massachusetts General Hospital, culminating in a Hematology-Oncology Fellowship at UCSF.

• Stanford University - BAS/MS
• Massachusetts Institute of Technology - PhD
• Harvard Medical School - MD

Dr. Wang’s research focuses on lung cancer, genetic mutations in tumors, and mechanisms of therapeutic resistance. She has pioneered work in liquid biopsies for circulating tumor DNA and rare cells, while also contributing to understanding transcriptional regulation via Oct1/VE proteins in early developmental biology.

Her publications demonstrate expertise in EGFR-mutant lung cancer evolution, ALK/ROS1 fusion oncogenes, PD-1/PD-L1 immunotherapy, and metabolic reprogramming in tumors. Key themes include precision oncology, genomic profiling, and translational research.

• Howard Hughes Predoctoral Fellowship (1997-2000)
• AACR-Amgen Clinical and Translational Fellowship (2013-2017)
• Damon Runyon Postdoctoral Fellowship (2014-2015)
• ASCO Career Development Award (2017)

Dr. Wang has collaborated on studies involving microfluidic filtration, ctDNA assays, and metastasis detection. Her work bridges basic science and clinical applications, with recent emphasis on resistance mechanisms to targeted therapies in lung and neuroendocrine cancers.